SCHEMBL24480263

SCHEMBL24480263

O=CN1CCN(C2CCNCC2)CC1

nearest known ligand 0.52

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KMT2A Q03164 2/20 0.36
HPGD P15428 1/20 0.36
SMN1; SMN2 Q16637 1/20 0.36
L3MBTL3 Q96JM7 1/20 0.34
L3MBTL1 Q9Y468 1/20 0.34
HRH3 Q9Y5N1 3/20 0.33
KHK P50053 4/20 0.32
KCNH2 Q12809 2/20 0.32
HTR2A P28223 1/20 0.32
HTR2C P28335 1/20 0.32
HTR6 P50406 1/20 0.31
LMNA P02545 1/20 0.31
CYP3A4 P08684 1/20 0.31
GABRA1 P14867 1/20 0.31
TSHR P16473 1/20 0.31
GABRG2 P18507 1/20 0.31
NFKB1 P19838 1/20 0.31
GABRB3 P28472 1/20 0.31
GABRA5 P31644 1/20 0.31
GABRA3 P34903 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1543398 0.84 HRH3 (0.40) KMT2AHRH3KCNH2MEN1TFPI2
SCHEMBL24582089 0.83 KMT2A (0.43) KMT2AHPGDSMN1; SMN2L3MBTL3L3MBTL1
SCHEMBL3159987 0.82 HTR6 (0.41) KMT2AHPGDSMN1; SMN2L3MBTL3L3MBTL1
SCHEMBL5429121 0.80 MEN1 (0.41) KMT2AHRH3KCNH2MEN1
SCHEMBL3083396 0.80 MEN1 (0.44) KMT2AL3MBTL3L3MBTL1HRH3KCNH2
SCHEMBL2554838 0.79 KMT2A (0.44) KMT2AHPGDSMN1; SMN2L3MBTL3L3MBTL1
SCHEMBL13632342 0.78 MEN1 (0.43) KMT2AHRH3KCNH2MEN1
SCHEMBL5016034 0.78 MEN1 (0.43) KMT2AL3MBTL3L3MBTL1HRH3KCNH2
SCHEMBL2318967 0.78 MEN1 (0.43) KMT2AHRH3KCNH2MEN1
SCHEMBL13632346 0.78 MEN1 (0.43) KMT2AHRH3KCNH2MEN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2022111526-A1 BENZENE RING DERIVATIVE, AND COMPOSITION AND PHARMACEUTICAL USE THEREOF 四川海思科制药有限公司 2022-06-02 WO disclosed